Results 1 to 10 of about 51,556 (181)

Haemophilus influenzae type b (Hib) seroprevalence in France: impact of vaccination schedules

open access: yesBMC Infectious Diseases, 2021
Background Haemophilus influenzae serotype b (Hib) conjugate vaccine was introduced in France in 1992 as a 3 + 1 scheme at 2, 3, and 4 months (primary vaccination) with a booster at the age of 16–18 months. The vaccination was simplified in 2013 to a 2 + 
Eva Hong   +6 more
doaj   +1 more source

Impact of mandatory vaccination against serogroup C meningococci in targeted and non-targeted populations in France

open access: yesnpj Vaccines, 2022
Since January 2018, mandatory vaccination against meningococci serogroup C has been implemented in France for children
Samy Taha   +2 more
doaj   +1 more source

Product review on the IMD serogroup B vaccine Bexsero®

open access: yesHuman Vaccines & Immunotherapeutics, 2022
Bexsero® is a multicomponent vaccine composed of four major proteins of Neisseria meningitidis: the fHbp, NHBA, NadA and PorA. This vaccine was licensed against invasive meningococcal disease (IMD) due to serogroup B isolates.
Ala-Eddine Deghmane, Muhamed-Kheir Taha
doaj   +1 more source

Haemophilus influenzae carriage and antibiotic resistance profile in Belgian infants over a three-year period (2016–2018)

open access: yesFrontiers in Microbiology, 2023
BackgroundNon-typeable Haemophilus influenzae has become increasingly important as a causative agent of invasive diseases following vaccination against H. influenzae type b.
Esra Ekinci   +13 more
doaj   +1 more source

Impact of COVID-19 pandemic and the lockdown on invasive meningococcal disease

open access: yesBMC Research Notes, 2020
Objective Few data are available on the association between SARS-CoV-2 and secondary bacterial infections. Such an association was described for flu and invasive meningococcal disease (IMD).
Muhamed-Kheir Taha, Ala-Eddine Deghmane
doaj   +1 more source

Analysis of Haemophilus species in patients with respiratory tract infections in Yaoundé, Cameroon

open access: yesInternational Journal of Infectious Diseases, 2020
Objectives: To identifyHaemophilus species and characterise the antimicrobial susceptibility of isolates from patients with respiratory tract infections (RTIs) in Cameroon.
Serges Tchatchouang   +11 more
doaj   +1 more source

Haemophilus influenzae Carriage among Healthy Children in Portugal, 2015–2019

open access: yesMicroorganisms, 2022
Haemophilus influenzae is an important cause of mucosal and invasive infections and a common colonizer of the upper respiratory tract. As there are no recent data on H.
Maria Paula Bajanca-Lavado   +6 more
doaj   +1 more source

Predicting bacteria causing acute bacterial rhinosinusitis by clinical features

open access: yesBrazilian Journal of Otorhinolaryngology, 2020
Introduction: Clinicians rely on clinical presentations to select therapeutic agents for acute bacterial rhinosinusitis. Streptococcus pneumoniae and Haemophilus influenzae are common in acute bacterial rhinosinusitis.
Dussawan Suwannawong   +7 more
doaj   +1 more source

Beta-lactamase-negative ampicillin-resistant Haemophilus influenzae type b meningitis in partially immunized immunocompetent child: a case report

open access: yesJournal of Medical Case Reports, 2021
Introduction Haemophilus influenzae is a Gram-negative coccobacillus that can cause many different kinds of infection, ranging from mild ear infection to life-threatening diseases like epiglottitis and meningitis.
Majid Ali Qureshi   +3 more
doaj   +1 more source

Transformability of Haemophilus influenzae [PDF]

open access: yesJournal of General Microbiology, 1962
SUMMARY: A method is described for the preparation of highly competent (transformable) bacteria of Haemophilus influenzae. After three successive treatments, i.e. aerobic growth, anaerobic incubation and incubation in saline containing a few per cent broth, transformation frequencies close to 5% have been obtained.
openaire   +2 more sources

Home - About - Disclaimer - Privacy